Navigation Links
Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
Date:5/5/2008

relevant to human obesity and suggest that metreleptin may be an effective partner to pramlintide in the treatment of obesity.

The full paper, published in the May 5, 2008 early edition of PNAS, is available online at http://www.pnas.org/. PNAS is one of the world's most prestigious multidisciplinary scientific journals.

About Obesity

Obesity is a chronic disorder that affects millions of people and is linked to increased health risk of several medical conditions including type 2 diabetes, high blood pressure, heart disease, stroke, osteoarthritis, sleep disorders and several types of cancers. According to The Obesity Society, obesity is the second leading cause of preventable death in the United States. The total direct and indirect cost attributed to overweight and obesity health issues exceeds $100 billion in the United States each year. Obesity is also rapidly becoming a major health problem in all industrialized nations and many developing countries.

Amylin's Approach to Obesity Research and Development

Physicians and patients seeking prescription medications for weight loss have limited therapeutic options. New scientific advances have established the key role of neurohormones in regulating appetite and energy balance, as well as the importance of studying the interaction among these hormones (within the brain) to uncover their full therapeutic potential. Amylin scientists discovered that combination treatment with neurohormones such as amylin and leptin can produce additive and synergistic weight loss in animal models. These findings formed the basis for Amylin's innovative integrated neurohormonal approach to the development of obesity treatments.

About Pramlintide and Metreleptin

Pramlintide is a synthetic analog of amylin, a neurohormone secreted by the pancreas that is known to play a role in the regulation of appetite, food intake and postprandial glucose c
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals Nicotinic Alpha-7 Agonist, MEM 3454
2. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
3. ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
4. Cequent Pharmaceuticals Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008
5. Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results
6. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Bavituximab Phase II Breast Cancer Trial
7. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
8. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
9. Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis
10. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
11. Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...THOUSAND OAKS, Calif., Nov. 21 /PRNewswire-FirstCa...at the European Committee for Medicinal,Products ... recommending,marketing authorisation for Nplate(...e CHMP recommends Nplate for adult chronic immune ...ectomised patients who are refractory to,other tr...
(Date:11/21/2008)...CLINTON, N.J., Nov. 21 Ikaria Hold...Private Company of the Year by the New Jersey Tech...rganization that provides business support, networ...echnology companies and their leaders. Ikaria earn...adership and unique product/service provision. , ...
(Date:11/20/2008)...WASHINGTON, Nov. 20 The...& Gender Equity: , , WHAT: World AIDS..., Tuesday, November 25, 2008 , 11:00 a.m. EST...ongly encouraged: https://cc.readytalk.com/r/1xe4...ns outpacing the number of people newly put on tre...
(Date:11/20/2008)... , , , , PHILADELPHIA, Nov. 20 /PRN...) today announced that the United States Food and ...oval for PROMACTA(R) (eltrombopag) for the treatme...mune (idiopathic) thrombocytopenic purpura (ITP) w...roids, immunoglobulins or splenectomy. The approva...
Breaking Medicine Technology:Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 2Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 3Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 4Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 5Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 6Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 7Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 8Ikaria(R) Named Private Company of the Year by New Jersey Technology Council 2Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Corgenix Signs Technology Licensing Agreement With Japanese Government 4049 1Corgenix Signs Technology Licensing Agreement With Japanese Government 4049 2Do bacterial combinations result in enhanced cytokine production 3F No 21 14573 1Do bacterial combinations result in enhanced cytokine production 3F No 21 14573 2Does stress damage the brain 3F 14568 1Does stress damage the brain 3F 14568 2Safe at Any Age 3A Octogenarians Do As Well as Younger Patients With Interventional Radiology Arterial Procedures 14563 1Safe at Any Age 3A Octogenarians Do As Well as Younger Patients With Interventional Radiology Arterial Procedures 14563 2Safe at Any Age 3A Octogenarians Do As Well as Younger Patients With Interventional Radiology Arterial Procedures 14563 3
...rvard Medical School ,Contributing Editor , ,... per year, breast cancer undoubtedly qualifies as ...ently, efforts to develop early detection methods ...gress. This is particularly true at the molecular...ve translated into new diagnostic tests and target...
...ibuting Editor ,Harvard Medical School ,The...two of the most important classes of fungi in clin...onment, and hospitals are no exception. Perhaps t...a ) and pulmonary hypersensitivity ( Aspergillus )...tions, but by virtue of intact physical barriers a...
Other Medicine Technology:Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy 2Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy 3New Assays to Detect Disseminated Fungal Infections 2New Assays to Detect Disseminated Fungal Infections 3
(Date:11/21/2008)...arents and schools need to work together to stop a... Nov. 21 (HealthDay News) -- Behavior that was onc... as bullying. , And as mounting research shows ...tim, mental-health professionals, schools, parents...ays to combat this threatening behavior. , "Bu...
(Date:11/21/2008)...D, Colo., Nov. 21 Heska ...will present at the New York Society of,Security ... Conference on,December 2, 2008 at 1177 Avenue of...sentation is scheduled to begin at 9:35 a.m. Easte...ilable via live webcast and for two weeks,followi...
(Date:11/21/2008)... might one day lead to a novel technique to combat... 21 (HealthDay News) -- Belgian researchers have d...nstead of sugar for food, and this might lead to n..., To survive and proliferate, all cells in the bo... sugar [glucose], a process that requires oxygen. ...
(Date:11/21/2008)...A, S.C., Nov. 21 U.S. N...for Quality Assurance (NCQA) ranked BlueChoice(R) ...merica,s Best Health Plans(TM), published in U.S. ..., The respected annual ranking ranks the nation,...ber satisfaction and NCQA accreditation scores. NC...
Breaking Medicine News(10 mins):Health News:Getting Tough on Bullying 2Health News:Getting Tough on Bullying 3Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2
...autopsy studies that women with Alzheimer’s diseas...heir brain tissue than women with a sound mental h...ena Li and colleges at the University of Chicago. ... models have already revealed that deficiency of e...
...ulsive need to shake legs while sitting or lying d...medical fraternity is not aware of it.// The cond...it difficult for patients to sit down comfortably ...ves or even while watching a movie, say experts. N...
...how old they get, never lose their beauty - they m... ~Martin Buxbaum Jacqueline Saburido was a very no... years ago. // A tragic incident that occurred on ... life. She met with a road traffic accident in whi...
...le professional lives often had the same kind of t...ers.// Physicians disciplined by state medical b...istory of unprofessional behavior while in medical...ipline records, says a study in New England Journa...
Other Medicine News:Health News:Lack Of Estrogen In Brain Tissue Of Women Can Lead To Alzheimer's 2Health News:Shaking Legs Syndrome Is Curable 2Health News:The Looming Controversy Surrounding Facial Transplant 2Health News:Bad professional behavior dates back to medical school 2Health News:Bad professional behavior dates back to medical school 3
...versatile means of sectioning fresh or fixed, anim...g blade principle which allows sectioning without ... the alteration of morphology, the destruction of ...nherent in freezing or embedding procedures are th...
...ovides a versatile means of sectioning fresh or fi... vibrating blade principle which allows sectioning...rtifacts, the alteration of morphology, the destru...effect inherent in freezing or embedding procedure...
...provides a versatile means of sectioning fresh or ... a vibrating blade principle which allows sectioni... artifacts, the alteration of morphology, the dest...s effect inherent in freezing or embedding procedu...
Instrument Cover for Vibratome.
Medicine Products: